Structure-based inhibitor design

被引：7

作者：

Craig, SP ^{[1
]}

Eakin, AE ^{[1
]}

机构：

[1] Univ N Carolina, Sch Pharm, Lab Mol Parasitol & Drug Design, Chapel Hill, NC 27599 USA

来源：

VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 58 | 2000年 / 58卷

关键词：

D O I：

10.1016/S0083-6729(00)58024-8

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：149 / +

页数：22

共 63 条

[11] The treatment of antiretroviral-naive subjects with the 3TC/zidovudine combination: A review of North American (NUCA 3081) and European (NUCB 3001) trials [J].

Eron, JJ .

AIDS, 1996, 10 :S11-S19

[12]

Fischer E, 1894, CHEM BER, V27, P2985

[13] Approaching the transition state in the crystal structure of a phosphoribosyltransferase [J].

Focia, PJ ;

Craig, SP ;

Eakin, AE .

BIOCHEMISTRY, 1998, 37 (49) :17120-17127

[14] A 1.4 Å crystal structure for the hypoxanthine phosphoribosyltransferase of Trypanosoma cruzi [J].

Focia, PJ ;

Craig, SP ;

Nieves-Alicea, R ;

Fletterick, RJ ;

Eakin, AE .

BIOCHEMISTRY, 1998, 37 (43) :15066-15075

[15] AMINO-ACIDS IN THE DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE GENE OF PLASMODIUM-FALCIPARUM INVOLVED IN CYCLOGUANIL RESISTANCE DIFFER FROM THOSE INVOLVED IN PYRIMETHAMINE RESISTANCE [J].

FOOTE, SJ ;

GALATIS, D ;

COWMAN, AF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) :3014-3017

[16]

FRICK L, 1989, DESIGN ENZYME INHIBI, P19

[17] PROGRESS IN ANTI-HIV STRUCTURE-BASED DRUG DESIGN [J].

GAIT, MJ ;

KARN, J .

TRENDS IN BIOTECHNOLOGY, 1995, 13 (10) :430-438

[18]

Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO

[19]

2-6

[20]

Gschwend DA, 1997, PROTEINS, V29, P59, DOI 10.1002/(SICI)1097-0134(199709)29:1&lt

← 1 2 3 4 5 6 7 →